GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scancell Holdings PLC (FRA:SCP) » Definitions » Pretax Margin %

Scancell Holdings (FRA:SCP) Pretax Margin % : % (As of Oct. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Scancell Holdings Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Scancell Holdings's Pre-Tax Income for the six months ended in Oct. 2023 was €-4.14 Mil. Scancell Holdings's Revenue for the six months ended in Oct. 2023 was €0.00 Mil. Therefore, Scancell Holdings's pretax margin for the quarter that ended in Oct. 2023 was %.

The historical rank and industry rank for Scancell Holdings's Pretax Margin % or its related term are showing as below:

FRA:SCP' s Pretax Margin % Range Over the Past 10 Years
Min: -271.37   Med: -271.37   Max: -271.37
Current: -271.37


FRA:SCP's Pretax Margin % is ranked worse than
56.41% of 1030 companies
in the Biotechnology industry
Industry Median: -155.98 vs FRA:SCP: -271.37

Scancell Holdings Pretax Margin % Historical Data

The historical data trend for Scancell Holdings's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scancell Holdings Pretax Margin % Chart

Scancell Holdings Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -271.40

Scancell Holdings Semi-Annual Data
Apr14 Oct14 Apr15 Oct15 Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -112.61 - -

Competitive Comparison of Scancell Holdings's Pretax Margin %

For the Biotechnology subindustry, Scancell Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scancell Holdings's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scancell Holdings's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Scancell Holdings's Pretax Margin % falls into.



Scancell Holdings Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Scancell Holdings's Pretax Margin for the fiscal year that ended in Apr. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Apr. 2023 )/Revenue (A: Apr. 2023 )
=-16.246/5.986
=-271.40 %

Scancell Holdings's Pretax Margin for the quarter that ended in Oct. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Oct. 2023 )/Revenue (Q: Oct. 2023 )
=-4.139/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Scancell Holdings  (FRA:SCP) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Scancell Holdings Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Scancell Holdings's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Scancell Holdings (FRA:SCP) Business Description

Traded in Other Exchanges
Address
Sanders Road, Unit 202, Bellhouse Building, Oxford Science Park, Oxford, GBR, OX4 4GD
Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. The company is exploiting the unrivalled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Its potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Its Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.

Scancell Holdings (FRA:SCP) Headlines

No Headlines